Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 7:51 PM
Ignite Modification Date: 2025-12-24 @ 7:51 PM
NCT ID: NCT06682104
Eligibility Criteria: Inclusion Criteria: * The participant certifies that they have undergone a medical evaluation for their physical symptoms. * The participant rates either moderate distress from physical symptoms on the PHQ-15 form (over 10 points) or significant distress from a single physical symptom (at least 2 points for that symptom). * The participant expresses interest in exploring whether emotional factors, such as stress, may contribute to their symptom profile. * Any prescribed medications must have been stable for at least 1 month. * Participants must meet the criteria for non-response/treatment resistance, i.e., no reliable change in PHQ-15. Exclusion Criteria: * Participants suffer from ongoing substance abuse (alcohol or drugs) or are assessed to have severe mental health issues (psychotic disorders, moderate to high suicide risk, antisocial personality disorder, etc.). * Participants are currently prescribed medications that are clearly addictive and sedative in nature (e.g., benzodiazepines). * Participants are involved in other psychological treatments focused on physical symptoms. However, other psychological treatments are allowed as long as the supportive therapy does not occur more than once a month. * Participants do not have sufficient proficiency in the Swedish language. * Somatic symptoms is judged to be need further medically evaluation or treatment.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT06682104
Study Brief:
Protocol Section: NCT06682104